BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu H, Zang P, Lee II, Anderson B, Christiani A, Strait-Bodey L, Breckheimer BA, Storie M, Tewnion A, Krumm K, Li T, Irwin B, Garcia JM. Growth hormone secretagogue receptor-1a mediates ghrelin's effects on attenuating tumour-induced loss of muscle strength but not muscle mass. J Cachexia Sarcopenia Muscle 2021;12:1280-95. [PMID: 34264027 DOI: 10.1002/jcsm.12743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kerr HL, Krumm K, Lee II, Anderson B, Christiani A, Strait L, Breckheimer BA, Irwin B, Jiang AS, Rybachok A, Chen A, Caeiro L, Dacek E, Hall DB, Kostyla CH, Hales LM, Soliman TM, Garcia JM. EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice. J Cachexia Sarcopenia Muscle 2023. [PMID: 36942661 DOI: 10.1002/jcsm.13211] [Reference Citation Analysis]
2 Herodes M, Anderson LJ, Shober S, Schur EA, Graf SA, Ammer N, Salas R, Marcelli M, Garcia JM. Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia. J Cachexia Sarcopenia Muscle 2023. [PMID: 36860137 DOI: 10.1002/jcsm.13191] [Reference Citation Analysis]
3 Carolina Monteiro A, Bonomo A. Breast-Tumor-Derived Bone Pre-Metastatic Disease: Interplay between Immune and Bone Cells within Bone Marrow Microenvironment. Bone Tumors - A Comprehensive Review of Selected Topics [Working Title] 2022. [DOI: 10.5772/intechopen.107278] [Reference Citation Analysis]
4 Khelifa MS, Skov LJ, Holst B. Biased Ghrelin Receptor Signaling and the Dopaminergic System as Potential Targets for Metabolic and Psychological Symptoms of Anorexia Nervosa. Front Endocrinol (Lausanne) 2021;12:734547. [PMID: 34646236 DOI: 10.3389/fendo.2021.734547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]